The Rise in Pediatric Obesity-Related Conditions and Costs in Public Insurance Programs: Evidence from Alabama

Bisakha Sen1, Pradeep Sharma1, Justin Blackburn2

  • 1Department of Health Care Organization and Policy, The University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA.

Insights

Pediatric obesity-related conditions (Ob-Cs) diagnoses and medical costs significantly increased in children on public insurance. Higher diagnosis rates were observed in minority and low-income groups, highlighting ongoing underdiagnosis concerns.

Area of Science:

  • Public Health
  • Pediatric Health
  • Health Economics

Background:

  • Pediatric obesity rates are rising globally.
  • The impact on obesity-related conditions (Ob-Cs) and healthcare costs in publicly insured children remains unclear.
  • Understanding these trends is crucial for resource allocation and intervention strategies.

Purpose of the Study:

  • To quantify the increase in Ob-C diagnoses among children enrolled in Alabama's Children's Health Insurance Program (ALL Kids).
  • To assess the associated changes in medical costs for these children from 1999 to 2015.
  • To identify demographic disparities in the trends of Ob-C diagnoses and costs.

Main Methods:

  • Retrospective analysis of linked claims and demographic data from Alabama's ALL Kids program (1999-2015).
  • Multivariate linear probability models estimated the likelihood of Ob-C diagnoses.
  • Two-part models analyzed inpatient, outpatient, emergency department, and overall healthcare costs.

Main Results:

  • The proportion of children with Ob-C diagnoses nearly doubled, from 1.3% to 2.5%.
  • Diagnosis likelihood increased annually, with higher rates among minority, low-income enrollees, and those receiving preventive care.
  • Healthcare costs for children with Ob-Cs rose significantly relative to those without, especially inpatient and outpatient expenses.

Conclusions:

  • Obesity-related conditions and associated medical costs have substantially increased in publicly insured children.
  • While past underdiagnosis may contribute, current underdiagnosis remains a significant issue.
  • Targeted interventions and improved diagnostic practices are needed, particularly for vulnerable populations.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
165
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
187
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
197